Last June 2017, the United States Food and Drug Administration (FDA) have released Draft Guidance regarding Product Identifier Requirements under the Drug Supply Chain Security Act (DSCSA).
Biosafety is defined as the discipline which addresses the containment and safe handling of infectious microorganisms and hazardous biological materials.
The International Society for Pharmaceutical Engineering (ISPE) released the term 'Advanced Aseptic Processing (AAP)', which covers both the Restricted Access Barrier System (RABS) and the isolators, which aims to cater for product protection and containment during on-going manufacturing operations by separating operators from the process.
The new medicinal technology, radionanomedicine, is the simultaneous application of nuclear medicine with nanomedicine. This takes advantage of radiomedicine using trace technology, where minute amounts of materials are biologically distributed in vivo.
What do implants, vaccines, allergenic extracts, dialysis and ophthalmic solutions have in common? Sterility.
Biocontainment involves the provision of a physical containment to prevent the unintentional infection of a personnel. Harmful discharge into the immediate workplace is also lessened during scientific research or manufacturing processes.
Oral solid dosage forms (OSDs) are one of the most prevalent drug delivery systems. Its market reached an estimate of $24.5 billion dollars back in 2016 and continually grows as the era for personalized medicine emerges.
Nutraceuticals contain nutrients derived from food products which are then formulated into different kinds of dosage forms. The definition of these drugs depends on their source - from natural resources, chemical syntheses, and pharmacological conditions.